Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Investors Video and Audio

The content of all investor relations materials contained on this website are deemed to be correct at the time of issue/publication.


Greg Madison of Shield Therapeutics discusses their US expansion, final results & financing agreement

Jul 2022 - 11:20

Shield Therapeutics talks extension of cash runway following US$10 million financing

Jul 2022 - 09:21

Greg Madison of Shield Therapeutics discusses the progress of their lead product in the U.S.

Feb 2022 - 12:32

Shield Therapeutics focus on US launch of Accrufer – increasing awareness and expand payer coverage

Feb 2022 - 12:04

Shield CEO Greg Madison talks to Proactive London about his strategy for the company and focus on driving our iron deficiency product Accrufer in the US

Aug 2021 - 12:10